SCHEMBL2686471

SCHEMBL2686471

CCCOc1ccc([SiH3])c(OCCC)c1OCCC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.42
▸ KDM4E B2RXH2 5/20 0.42
▸ MAPT P10636 5/20 0.42
▸ POLB P06746 3/20 0.42
▸ MEN1 O00255 2/20 0.42
▸ HTT P42858 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ USP2 O75604 1/20 0.42
▸ TP53 P04637 1/20 0.42
▸ GAA P10253 1/20 0.42
▸ CASP1 P29466 1/20 0.42
▸ CASP7 P55210 1/20 0.42
▸ ATM Q13315 1/20 0.42
▸ LMNA P02545 3/20 0.39
▸ HPGD P15428 3/20 0.39
▸ TSHR P16473 2/20 0.39
▸ HSD17B10 Q99714 2/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ PLA2G1B P04054 1/20 0.39
▸ ATG4B Q9Y4P1 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5032298 0.90 LMNA (0.43) ALDH1A1KDM4EMAPTGAALMNA
SCHEMBL5373491 0.89 MCHR1 (0.40) ALDH1A1KDM4EMAPTMEN1KMT2A
SCHEMBL9420344 0.82 SMN1; SMN2 (0.34) KDM4EMAPTPOLBHTTKMT2A
SCHEMBL5034245 0.82 CSNK2A1 (0.43) ALDH1A1KDM4EMAPTPOLBMEN1
SCHEMBL21825587 0.80 KDM4E (0.33) ALDH1A1KDM4EMAPTPOLBMEN1
SCHEMBL158540 0.79 ALDH1A1 (0.41) ALDH1A1KDM4EMAPTPOLBMEN1
SCHEMBL1984241 0.76 CYP1A2 (0.52) ALDH1A1KDM4EMAPTGAALMNA
SCHEMBL1835382 0.76 KDM4E (0.42) ALDH1A1KDM4EMAPTPOLBMEN1
SCHEMBL8220033 0.76 ALDH1A1 (0.44) ALDH1A1KDM4EMAPTPOLBMEN1
SCHEMBL29091824 0.74 CYP1A2 (0.52) ALDH1A1KDM4EMAPTLMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7186782-B2 Hydrogenation catalyst composition and process for hydrogenation of conjugated diene polymer TSRC CORPORATION (TW) 2007-03-06 — — US claimed
US-20060041079-A1 Hydrogenation catalyst composition and process for hydrogenation of conjugated diene polymer TSRC CORPORATION 2006-02-23 — — US claimed
WO-2024176969-A1 METHOD FOR PRODUCING CARBONIC ACID DIESTER 国立研究開発法人産業技術総合研究所 2024-08-29 — — WO disclosed
US-20230087596-A1 ESTER COMPOUND, METHOD FOR PRODUCING SAME, POLYMER, THERMOSETTING RESIN COMPOSITION AND CURED FILM KYOEISHA CHEMICAL CO., LTD. (JP) 2023-03-23 — — US disclosed
EP-4067395-A1 ESTER COMPOUND, METHOD FOR PRODUCING SAME, POLYMER, THERMOSETTING RESIN COMPOSITION AND CURED FILM Kyoeisha Chemical Co., Ltd. (JP) 2022-10-05 — — EP disclosed
CN-114829415-A Ester compound, method for producing same, polymer, thermosetting resin composition, and cured film 共荣社化学株式会社 2022-07-29 — — CN disclosed
WO-2021132251-A1 ESTER COMPOUND, METHOD FOR PRODUCING SAME, POLYMER, THERMOSETTING RESIN COMPOSITION AND CURED FILM 共栄社化学株式会社 2021-07-01 — — WO disclosed
WO-2021131030-A1 ESTER COMPOUND, PRODUCTION METHOD THEREFOR, POLYMER, THERMALLY CURABLE RESIN COMPOSITION, AND CURED FILM 共栄社化学株式会社 2021-07-01 — — WO disclosed
WO-2017144401-A1 LUMINESCENT PARTICLES BASF SE (DE) 2017-08-31 — — WO disclosed
WO-2017036997-A1 PROCESS FOR FORMULATING QUANTUM DOTS BASF SE (DE) 2017-03-09 — — WO disclosed
US-8168739-B2 Polysiloxane, method for producing the same, and method for producing cured product of the same TOAGOSEI CO., LTD. (JP) 2012-05-01 — — US disclosed
US-20100280210-A1 POLYSILOXANE, METHOD FOR PRODUCING THE SAME, AND METHOD FOR PRODUCING CURED PRODUCT OF THE SAME TOAGOSEI CO., LTD. (JP) 2010-11-04 — — US disclosed
US-7466893-B2 Curable resin composition for light guide formation, curable dry film for light guide formation, cured resin and light guide KANSAI PAINT CO., LTD. (JP) 2008-12-16 — — US disclosed
US-20080226245-A1 Epoxy resin that is modified with a tetraalkoxysilane or alkyltrialkoxysilane to form a hydrolyzable resin and another resin that is reactive with an epoxy group, such as an acrylic acid-acrylate copolymer; optical waveguides with high heat resistance, excellent mechanical strength and transparency KANSAI PAINT CO., LTD. (JP) 2008-09-18 — — US disclosed
US-20070213204-A1 Ziegler-Natta catalyst with in situ-generated donor NOVOLEN TECHNOLOGY HOLDINGS C.V. 2007-09-13 — — US disclosed
US-7186782-B2 Hydrogenation catalyst composition and process for hydrogenation of conjugated diene polymer TSRC CORPORATION (TW) 2007-03-06 — — US disclosed
US-20060041079-A1 Hydrogenation catalyst composition and process for hydrogenation of conjugated diene polymer TSRC CORPORATION 2006-02-23 — — US disclosed
US-5731037-A CONTROLLING SURFACE MOISTURE OF BUILDING MATERIAL KANSAI PAINT CO., LTD. (JP) 1998-03-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230087596-A1 ESTER COMPOUND, METHOD FOR PRODUCING SAME, POLYMER, THERMOSETTING RESIN COMPOSITION AND CURED FILM RER1, EMG1, SETDB1 ALDH1A1 1084/4885KDM4E 222/4885MAPT 714/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback